HR 449
115th Congress
House
Health
Child health
Congressional oversight
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Synthetic Drug Awareness Act of 2017
Everywhere this bill has been
15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2018
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 12, 2018
The title of the measure was amended. Agreed to without objection.
Jun 12, 2018
Motion to reconsider laid on the table Agreed to without objection. (text: CR H5029)
Jun 12, 2018
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Jun 12, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Jun 12, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 449.
Jun 12, 2018
Considered under suspension of the rules. (consideration: CR H5029-5031)
Jun 12, 2018
Mr. Latta moved to suspend the rules and pass the bill, as amended.
May 9, 2018
Ordered to be Reported (Amended) by Voice Vote.
May 9, 2018
Committee Consideration and Mark-up Session Held.
Apr 25, 2018
Forwarded by Subcommittee to Full Committee (Amended) by Unanimous Consent .
Apr 25, 2018
Subcommittee Consideration and Mark-up Session Held.
Jan 25, 2017
Referred to the Subcommittee on Health.
Jan 11, 2017
Referred to the House Committee on Energy and Commerce.
Jan 11, 2017
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Synthetic Drug Awareness Act of 2017
This bill requires the Surgeon General to report to Congress on the public health effects of the increased use since January 2010 by individuals who are 12 to 18 years old of drugs developed and manufactured to avoid control under the Controlled Substances Act (e.g., synthetic marijuana, also known as "spice," and synthetic amphetamines, also known as "bath salts").
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Related & companion bills
2
Bill text
3 versions
- Engrossed in House Formatted Text PDF Formatted XML
- Introduced in House Formatted Text PDF Formatted XML
- Referred in Senate Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cosponsors
30
R
Bost, Mike
WALDEN, GREG
R
Blackburn, Marsha
Faso, John
D
DeSaulnier, Mark
D
Khanna, Ro
D
Krishnamoorthi, Raja
D
Ruiz, Raul
D
Peters, Scott H.
D
Tonko, Paul
D
Norcross, Donald
R
Walberg, Tim
D
Clarke, Yvette D.
R
Fitzpatrick, Brian K.
Jenkins, Evan
MacArthur, Thomas
Walters, Mimi
D
Blunt Rochester, Lisa
Comstock, Barbara
R
Allen, Rick W.
R
Joyce, David P.
R
Bilirakis, Gus M.
Rooney, Thomas
THORNBERRY, WILLIAM
Donovan, Daniel
R
Stefanik, Elise M.
R
Cramer, Kevin
Collins, Chris
Gowdy, Trey
Meehan, Patrick
Cite this page
U.S. Congress. (2026). H.R. 449: Synthetic Drug Awareness Act of 2018. 115th Congress. Open America. https://openamerica.io/bill/115-HR-449/
"H.R. 449: Synthetic Drug Awareness Act of 2018." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-449/.
H.R. 449, 115th Cong. (2026), https://openamerica.io/bill/115-HR-449/.
[H.R. 449: Synthetic Drug Awareness Act of 2018](https://openamerica.io/bill/115-HR-449/)